Nicholas J Keeling1, Tyler J Dunn2, John P Bentley1, Sujith Ramachandran1, James M Hoffman3, Meagen Rosenthal1. 1. Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS, USA. 2. Department of Pharmacy Administration, University of Mississippi School of Pharmacy, University, MS, USA. tdunn@go.olemiss.edu. 3. Department of Pharmaceutical Sciences and Office of Quality and Patient Care, St. Jude Children's Research Hospital, Memphis, TN, USA.
Abstract
PURPOSE: Barriers to the implementation of pharmacogenomics in clinical practice have been thoroughly discussed over the past decade. METHODS: The objective of this scoping review was to characterize the peer-reviewed literature surrounding the experiences and actions of prescribers, pharmacists, or genetic counselors when using pharmacogenomic information in real-world or hypothetical research settings. RESULTS: A total of 33 studies were included in the scoping review. The majority of studies were conducted in the United States (70%), used quantitative or mixed methods (79%) with physician or pharmacist respondents (100%). The qualitative content analysis revealed five major methodological approaches: hypothetical clinical case scenarios, real-world studies evaluating prescriber response to recommendations or alerts, cross-sectional quantitative surveys, cross-sectional qualitative surveys/interviews, and a quasi-experimental real-world study. CONCLUSION: The findings of this scoping review can guide further research on the factors needed to successfully integrate pharmacogenomics into clinical care.
PURPOSE: Barriers to the implementation of pharmacogenomics in clinical practice have been thoroughly discussed over the past decade. METHODS: The objective of this scoping review was to characterize the peer-reviewed literature surrounding the experiences and actions of prescribers, pharmacists, or genetic counselors when using pharmacogenomic information in real-world or hypothetical research settings. RESULTS: A total of 33 studies were included in the scoping review. The majority of studies were conducted in the United States (70%), used quantitative or mixed methods (79%) with physician or pharmacist respondents (100%). The qualitative content analysis revealed five major methodological approaches: hypothetical clinical case scenarios, real-world studies evaluating prescriber response to recommendations or alerts, cross-sectional quantitative surveys, cross-sectional qualitative surveys/interviews, and a quasi-experimental real-world study. CONCLUSION: The findings of this scoping review can guide further research on the factors needed to successfully integrate pharmacogenomics into clinical care.
Authors: Brittany A Borden; Paige Galecki; Rebecca Wellmann; Keith Danahey; Sang Mee Lee; Linda Patrick-Miller; Matthew J Sorrentino; Rita Nanda; Jay L Koyner; Tamar S Polonsky; Walter M Stadler; Cathleen Mulcahy; Robert T Kavitt; Mark J Ratain; David O Meltzer; Peter H O'Donnell Journal: Pharmacogenet Genomics Date: 2019-02 Impact factor: 2.089
Authors: Kristen B McCullough; Christine M Formea; Kevin D Berg; Julianna A Burzynski; Julie L Cunningham; Narith N Ou; Maria I Rudis; Joanna L Stollings; Wayne T Nicholson Journal: Am J Pharm Educ Date: 2011-04-11 Impact factor: 2.047
Authors: Amy A Lemke; Christina G Hutten Selkirk; Nicole S Glaser; Annette W Sereika; Dyson T Wake; Peter J Hulick; Henry M Dunnenberger Journal: Per Med Date: 2017-08-02 Impact factor: 2.512
Authors: Stefanie P Ferreri; Angelo J Greco; Natasha M Michaels; Shanna K O'Connor; Rebecca W Chater; Anthony J Viera; Hawazin Faruki; Howard L McLeod; Mary W Roederer Journal: J Am Pharm Assoc (2003) Date: 2014 Mar-Apr
Authors: Lucas M Walden; Eva J Brandl; Amtul Changasi; Jessica E Sturgess; Alexander Soibel; Janna Fe D Notario; Sheraz Cheema; Nicole Braganza; Victoria S Marshe; Natalie Freeman; Arun K Tiwari; James L Kennedy; Daniel J Müller Journal: Psychiatry Res Date: 2015-08-07 Impact factor: 3.222
Authors: Alan J McMichael; Marco Boeri; Jonathan J Rolison; Joe Kane; Francis A O'Neill; Ric Scarpa; Frank Kee Journal: Value Health Date: 2016-11-04 Impact factor: 5.725
Authors: Samuel Ubanyionwu; Christine M Formea; Benjamin Anderson; Kelly Wix; Ross Dierkhising; Pedro J Caraballo Journal: Am J Health Syst Pharm Date: 2018-02-15 Impact factor: 2.637
Authors: Edith A Nutescu; Katarzyna Drozda; Adam P Bress; William L Galanter; James Stevenson; Thomas D Stamos; Ankit A Desai; Julio D Duarte; Victor Gordeuk; David Peace; Shrihari S Kadkol; Carol Dodge; Santosh Saraf; John Garofalo; Jerry A Krishnan; Joe G N Garcia; Larisa H Cavallari Journal: Pharmacotherapy Date: 2013-07-17 Impact factor: 4.705
Authors: Emily Beth Devine; Chia-Ju Lee; Casey L Overby; Neil Abernethy; Jeannine McCune; Joe W Smith; Peter Tarczy-Hornoch Journal: Int J Med Inform Date: 2014-05-09 Impact factor: 4.046